HALL BRETT MATTHEW (Chief Scientific Officer) purchased 3.9% of their position (13.42K shares) of IMMUNEERING CORP on the open market
Open‑market purchase worth $34.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/24/2025ACC: 0001790340-25-000087
Officer· Chief Scientific Officer
Since Jul 2021
+13.42K
Net shares
Net buyer
$34.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
13.42K acquired
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+7.42K
Price / share
$2.70
Trade value
$20.02K
% of position
2.1%
6/20/2025
345.90K→353.31K
Class A Common Stock
Direct
Shares
+6.01K
Price / share
$2.43
Trade value
$14.60K
% of position
1.7%
6/23/2025
353.31K→359.32K
Total
Net shares
+13.42K
Net value
$34.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/20/2025 | P · Purchase | +7.42K | $2.70 | $20.02K | 2.1% | 345.90K | 353.31K |
| Class A Common Stock Direct | 6/23/2025 | P · Purchase | +6.01K | $2.43 | $14.60K | 1.7% | 353.31K | 359.32K |
| Total | +13.42K | $34.62K | ||||||
Derivative Transactions0
No derivative transactions reported